Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

Int J Mol Sci. 2024 Nov 25;25(23):12637. doi: 10.3390/ijms252312637.

Abstract

Neurodegeneration is preeminent in many neurological diseases, and still a major burden we fail to manage in patient's care. Its pathogenesis is complicated, intricate, and far from being completely understood. Taking multiple sclerosis as an example, we propose that neurodegeneration is neither a cause nor a consequence by itself. Mitochondrial dysfunction, leading to energy deficiency and ion imbalance, plays a key role in neurodegeneration, and is partly caused by the oxidative stress generated by microglia and astrocytes. Nodal and paranodal disruption, with or without myelin alteration, is further involved. Myelin loss exposes the axons directly to the inflammatory and oxidative environment. Moreover, oligodendrocytes provide a singular metabolic and trophic support to axons, but do not emerge unscathed from the pathological events, by primary myelin defects and cell apoptosis or secondary to neuroinflammation or axonal damage. Hereby, trophic failure might be an overlooked contributor to neurodegeneration. Thus, a complex interplay between neuroinflammation, demyelination, and neurodegeneration, wherein each is primarily and secondarily involved, might offer a more comprehensive understanding of the pathogenesis and help establishing novel therapeutic strategies for many neurological diseases and beyond.

Keywords: Alzheimer’s disease; Parkinson’s disease; demyelination; metabolic syndrome; multiple sclerosis; neurodegeneration; neuroinflammation.

Publication types

  • Review

MeSH terms

  • Animals
  • Axons / metabolism
  • Axons / pathology
  • Demyelinating Diseases* / metabolism
  • Demyelinating Diseases* / pathology
  • Humans
  • Microglia / metabolism
  • Microglia / pathology
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Multiple Sclerosis* / metabolism
  • Multiple Sclerosis* / pathology
  • Myelin Sheath / metabolism
  • Myelin Sheath / pathology
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / pathology
  • Neuroinflammatory Diseases* / etiology
  • Neuroinflammatory Diseases* / metabolism
  • Neuroinflammatory Diseases* / pathology
  • Oligodendroglia / metabolism
  • Oligodendroglia / pathology
  • Oxidative Stress

Grants and funding

This research received no external funding.